Frontiers in Oncology | Hematologic Malignancies

Systematic Review

Published on 16 Feb 2023

Post-transplant cyclophosphamide versus anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation from unrelated donors: A systematic review and meta-analysis

in Hematologic Malignancies

Lu Tang
Zhigang Liu
Tao Li
Tian Dong
Qiuhui Wu
Ting Niu
Ting Liu
Jie Ji

Frontiers in Oncology

doi 10.3389/fonc.2023.1071268

5,550 views
17 citations

Original Research

Published on 16 Feb 2023

Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles

in Hematologic Malignancies

Xinyue Deng
Meilan Zhang
Jiachen Wang
Xiaoxi Zhou
Min Xiao

Frontiers in Oncology

doi 10.3389/fonc.2023.1120867

3,274 views
4 citations

Original Research

Published on 16 Feb 2023

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study

in Hematologic Malignancies

Junbin Huang
Guanhua Hu
Pan Suo
Lu Bai
Yifei Cheng
Yu Wang
XiaoHui Zhang
KaiYan Liu
YuQian Sun
LanPing Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1116205

3,626 views
8 citations

Original Research

Published on 15 Feb 2023

A diagnostic scoring model of ENKTCL in the nose-Waldeyer’s ring based on logistic regression: Differential diagnosis from DLBCL

in Hematologic Malignancies

Jun-Yi Xiang
Xiao-Shan Huang
Na Feng
Xiao-Zhong Zheng
Qin-Pan Rao
Li-Ming Xue
Lin-Ying Ma
Ying Chen
Jian-Xia Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1065440

2,390 views
2 citations

Original Research

Published on 15 Feb 2023

Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21

in Hematologic Malignancies

Claudia Giordano
Marco Picardi
Novella Pugliese
Annamaria Vincenzi
Davide Pio Abagnale
Laura De Fazio
Maria Luisa Giannattasio
Carmina Fatigati
Mauro Ciriello
Alessia Salemme

Frontiers in Oncology

doi 10.3389/fonc.2023.1130899

3,592 views
6 citations

Correction

Published on 14 Feb 2023

Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

in Hematologic Malignancies

Huijuan Zhao
Ziqing Wei
Guomin Shen
Yixiang Chen
Xueqin Hao
Sanqiang Li
Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1132485

1,478 views

Editorial

Published on 14 Feb 2023

Editorial: Epidemiological trends in hematological malignancies

in Hematologic Malignancies

Marcos de Lima
Jorge Castillo
Michele Merli
Valentin Garcia-Gutierrez

Frontiers in Oncology

doi 10.3389/fonc.2023.1151774

2,743 views
1 citation

Review

Published on 14 Feb 2023

Measurable residual disease in chronic lymphocytic leukemia

in Hematologic Malignancies

Giulia Benintende
Federico Pozzo
Idanna Innocenti
Francesco Autore
Alberto Fresa
Giovanni D’Arena
Valter Gattei
Luca Laurenti

Frontiers in Oncology

doi 10.3389/fonc.2023.1112616

11,655 views
8 citations

Original Research

Published on 14 Feb 2023

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine

in Hematologic Malignancies

Giuseppe A. Palumbo
Daniela Cambria
Enrico La Spina
Andrea Duminuco
Antonio Laneri
Anna Longo
Calogero Vetro
Sebastiano Giallongo
Alessandra Romano
Francesco Di Raimondo

Frontiers in Oncology

doi 10.3389/fonc.2023.1117815

5,169 views
18 citations

Original Research

Published on 10 Feb 2023

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma

in Hematologic Malignancies

Dandan Gao
Rui Liu
Yang Lv
Yuandong Feng
Fei Hong
Xuezhu Xu
Jinsong Hu
Aili He
Yun Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.999688

6,613 views
18 citations

Original Research

Published on 10 Feb 2023

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas

in Hematologic Malignancies

Jin Ju Kim
Hyun-Young Kim
Zisun Choi
So yoon Hwang
Hansol Jeong
Jong Rak Choi
Sang Eun Yoon
Won Seog Kim
Sun-Hee Kim
Hee-Jin Kim

Frontiers in Oncology

doi 10.3389/fonc.2023.1109715

4,449 views
12 citations

Opinion

Published on 09 Feb 2023

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?

in Hematologic Malignancies

Jennifer Edelmann
Jitka Malcikova
John C. Riches

Frontiers in Oncology

doi 10.3389/fonc.2023.1106579

6,775 views
2 citations

Original Research

Published on 09 Feb 2023

Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients

in Hematologic Malignancies

Shilpi Chaudhary
Shuvadeep Ganguly
Jayanth Kumar Palanichamy
Archna Singh
Dibyabhaba Pradhan
Radhika Bakhshi
Anita Chopra
Sameer Bakhshi

Frontiers in Oncology

doi 10.3389/fonc.2023.1109518

5,686 views
8 citations

Original Research

Published on 09 Feb 2023

Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study

in Hematologic Malignancies

Wei Zhou
Guofeng Chen
Dan Gong
Yi Gao
Li Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1138853

3,892 views
7 citations

Review

Published on 09 Feb 2023

PTCL, NOS: An update on classification, risk-stratification, and treatment

in Hematologic Malignancies

Jonathan Weiss
John Reneau
Ryan A. Wilcox

Frontiers in Oncology

doi 10.3389/fonc.2023.1101441

16,359 views
19 citations

Original Research

Published on 09 Feb 2023

High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics

in Hematologic Malignancies

Yuan Xia
Na Shen
Run Zhang
Yujie Wu
Qinglin Shi
Jianyong Li
Lijuan Chen
Min Xu
Yuanyuan Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1083053

4,887 views
14 citations

Review

Published on 08 Feb 2023

Tyrosine kinases in nodal peripheral T-cell lymphomas

in Hematologic Malignancies

Pier Paolo Piccaluga
Chiara Cascianelli
Giorgio Inghirami

Frontiers in Oncology

doi 10.3389/fonc.2023.1099943

4,479 views
8 citations

Review

Published on 07 Feb 2023

Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature

in Hematologic Malignancies

Cesare Mazzaro
Riccardo Bomben
Marcella Visentini
Laura Gragnani
Luca Quartuccio
Francesco Saccardo
Marco Sebastiani
Davide Filippini
Gianfranco Lauletta
Giuseppe Monti

Frontiers in Oncology

doi 10.3389/fonc.2023.1095780

8,185 views
10 citations

Review

Published on 07 Feb 2023

Research progress on molecular biomarkers of acute myeloid leukemia

in Hematologic Malignancies

Pei-Yuan Yin
Rui-Wen Wang
Rui Jing
Xing Li
Jing-Hua Ma
Kai-Min Li
Hua Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1078556

8,840 views
9 citations

Systematic Review

Published on 07 Feb 2023

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review

in Hematologic Malignancies

Stephen Jolles
Sergio Giralt
Tessa Kerre
Hillard M. Lazarus
S. Shahzad Mustafa
Roberto Ria
Donald C. Vinh

Frontiers in Oncology

doi 10.3389/fonc.2023.1098326

9,761 views
20 citations

Mini Review

Published on 06 Feb 2023

Myeloid leukemia factor 1: A “double-edged sword” in health and disease

in Hematologic Malignancies

Zixuan Li
Yuanyuan Yang
Kun Wu
Yuntao Li
Mingxia Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1124978

3,849 views
5 citations

Original Research

Published on 01 Feb 2023

High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

in Hematologic Malignancies

Junlin Zhang
Liying Liu
Jinshuang Wei
Xiaojing Wu
Jianming Luo
Hongying Wei
Liao Ning
Yunyan He

Frontiers in Oncology

doi 10.3389/fonc.2022.1068094

5,981 views
14 citations

Case Report

Published on 31 Jan 2023

Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report

in Hematologic Malignancies

Runan Wang
Wenliang Wang
Xuan Liu
Huan Wang
Bin Zhang
Shuang Li
Haining Zhang
Jiawei Yang
Jishun Zhao
Qiuying He

Frontiers in Oncology

doi 10.3389/fonc.2022.1018250

3,896 views
2 citations

Original Research

Published on 31 Jan 2023

Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia

in Hematologic Malignancies

Shenrui Bai
Huizhong Wang
Ruonan Shao
Bibo Fu
Shujing Lu
Jingzi Wang
Yue Lu
Hua Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.950732

3,958 views
8 citations

2,053 articles

articles

Post-transplant cyclophosphamide versus anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation from unrelated donors: A systematic review and meta-analysis

Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study

A diagnostic scoring model of ENKTCL in the nose-Waldeyer’s ring based on logistic regression: Differential diagnosis from DLBCL

Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21

Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

Editorial: Epidemiological trends in hematological malignancies

Measurable residual disease in chronic lymphocytic leukemia

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?

Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients

Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study

PTCL, NOS: An update on classification, risk-stratification, and treatment

High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics

Tyrosine kinases in nodal peripheral T-cell lymphomas

Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature

Research progress on molecular biomarkers of acute myeloid leukemia

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review

Myeloid leukemia factor 1: A “double-edged sword” in health and disease

High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report

Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia